Your search returned 4 results.

Results
	1.	Activity of decitabine, a hypomethylating agent, in chronic myelomonocytic leukemia. [electronic resource] by Aribi, Ahmed Borthakur, Gautam Ravandi, Farhad Shan, Jianqin Davisson, Jan Cortes, Jorge Kantarjian, Hagop Producer: 20070313 In: Cancer vol. 109 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Update of the decitabine experience in higher risk myelodysplastic syndrome and analysis of prognostic factors associated with outcome. [electronic resource] by Kantarjian, Hagop M O'Brien, Susan Shan, Jianqin Aribi, Ahmed Garcia-Manero, Guillermo Jabbour, Elias Ravandi, Farhad Cortes, Jorge Davisson, Jan Issa, Jean-Pierre Producer: 20070226 In: Cancer vol. 109 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Survival advantage with decitabine versus intensive chemotherapy in patients with higher risk myelodysplastic syndrome: comparison with historical experience. [electronic resource] by Kantarjian, Hagop M O'Brien, Susan Huang, Xuelin Garcia-Manero, Guillermo Ravandi, Farhad Cortes, Jorge Shan, Jianqin Davisson, Jan Bueso-Ramos, Carlos E Issa, Jean-Pierre Producer: 20070521 In: Cancer vol. 109 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	A proof-of-principle pharmacokinetic, pharmacodynamic, and clinical study with purine nucleoside phosphorylase inhibitor immucillin-H (BCX-1777, forodesine). [electronic resource] by Gandhi, Varsha Kilpatrick, John M Plunkett, William Ayres, Mary Harman, Leigh Du, Min Bantia, Shanta Davisson, Jan Wierda, William G Faderl, Stefan Kantarjian, Hagop Thomas, Deborah Producer: 20060106 In: Blood vol. 106 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)